Fund shareholders of Caris Life Sciences Inc
ISIN US1421521071 · United States · LEI 549300LX5LO78M5VPY43
- Fund shareholders
- 237
- Of which ETFs
- 41 196 other funds
- Value held
- 1.1B $
- Share of capital
- 20.2 % of 282.6M shares on Aug 3, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 3,155,698 | 56.4M $ | 0.00 % | 1.12 % | as of Mar 31, 2026 ↗ |
| Select Health Care Portfolio Fidelity Select Portfolios | 3,050,000 | 61.4M $ | 0.99 % | 1.08 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Mid-Cap Growth Fund, Inc. T. ROWE PRICE MID-CAP GROWTH FUND, INC. | 2,704,204 | 48.4M $ | 0.21 % | 0.96 % | as of Mar 31, 2026 ↗ |
| Select Medical Technology and Devices Portfolio Fidelity Select Portfolios | 2,700,000 | 54.4M $ | 1.49 % | 0.96 % | as of Feb 28, 2026 ↗ |
| VIP Mid Cap Portfolio Variable Insurance Products Fund III | 2,693,500 | 48.2M $ | 0.60 % | 0.95 % | as of Mar 31, 2026 ↗ |
| Fidelity Contrafund Fidelity Contrafund | 2,332,471 | 41.7M $ | 0.03 % | 0.83 % | as of Mar 31, 2026 ↗ |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 2,274,539 | 40.7M $ | 0.02 % | 0.80 % | as of Mar 31, 2026 ↗ |
| Strategic Advisers Fidelity U.S. Total Stock Fund Fidelity Rutland Square Trust II | 2,139,300 | 43.1M $ | 0.02 % | 0.76 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 1,909,867 | 34.1M $ | 0.31 % | 0.68 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor Health Care Fund Fidelity Advisor Series VII | 1,800,000 | 34.2M $ | 1.18 % | 0.64 % | as of Apr 30, 2026 ↗ |
| JPMorgan Mid Cap Growth Fund JPMorgan Trust II | 1,691,144 | 30.2M $ | 0.27 % | 0.60 % | as of Mar 31, 2026 ↗ |
| Fidelity Mid-Cap Stock Fund Fidelity Concord Street Trust | 1,353,400 | 25.7M $ | 0.29 % | 0.48 % | as of Apr 30, 2026 ↗ |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 1,273,266 | 22.8M $ | 0.06 % | 0.45 % | as of Mar 31, 2026 ↗ |
| Fidelity Puritan Fund Fidelity Puritan Trust | 1,242,900 | 25M $ | 0.08 % | 0.44 % | as of Feb 28, 2026 ↗ |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 1,235,594 | 24.9M $ | 0.03 % | 0.44 % | as of Feb 28, 2026 ↗ |
| Fidelity U.S. Equity Central Fund Fidelity Central Investment Portfolios LLC | 1,200,000 | 21.5M $ | 0.11 % | 0.42 % | as of Mar 31, 2026 ↗ |
| SMALLCAP World Fund Inc SMALLCAP World Fund Inc | 1,180,173 | 21.1M $ | 0.03 % | 0.42 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Growth Fund Fidelity Securities Fund | 1,124,760 | 21.4M $ | 0.25 % | 0.40 % | as of Apr 30, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 898,011 | 16.1M $ | 0.20 % | 0.32 % | as of Mar 31, 2026 ↗ |
| Invesco Discovery Fund AIM Counselor Series Trust (Invesco Counselor Series Trust) | 803,618 | 16.2M $ | 0.24 % | 0.28 % | as of Feb 28, 2026 ↗ |
| Fidelity Balanced Fund Fidelity Puritan Trust | 726,400 | 14.6M $ | 0.02 % | 0.26 % | as of Feb 28, 2026 ↗ |
| ClearBridge Small Cap Growth Fund Legg Mason Partners Investment Trust | 660,546 | 12.6M $ | 0.63 % | 0.23 % | as of Apr 30, 2026 ↗ |
| Columbia Small Cap Growth Fund COLUMBIA FUNDS SERIES TRUST I | 638,423 | 12.9M $ | 0.40 % | 0.23 % | as of Feb 28, 2026 ↗ |
| VIP Health Care Portfolio Variable Insurance Products Fund IV | 590,000 | 10.5M $ | 1.05 % | 0.21 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 588,972 | 10.5M $ | 0.08 % | 0.21 % | as of Mar 31, 2026 ↗ |
| Fidelity Stock Selector Small Cap Fund Fidelity Capital Trust | 575,800 | 10.9M $ | 0.16 % | 0.20 % | as of Apr 30, 2026 ↗ |
| Fidelity Small Cap Growth K6 Fund Fidelity Securities Fund | 563,256 | 10.7M $ | 0.25 % | 0.20 % | as of Apr 30, 2026 ↗ |
| Fidelity Advisor Mid Cap II Fund Fidelity Advisor Series I | 559,500 | 10M $ | 0.60 % | 0.20 % | as of Mar 31, 2026 ↗ |
| Champlain Small Company Fund ADVISORS' INNER CIRCLE FUND II | 556,000 | 9.9M $ | 0.97 % | 0.20 % | as of Mar 31, 2026 ↗ |
| Nuveen Quant Mid Cap Growth Fund TIAA-CREF Funds | 527,890 | 10M $ | 1.47 % | 0.19 % | as of Apr 30, 2026 ↗ |
| Fidelity Contrafund K6 Fidelity Contrafund | 500,750 | 9M $ | 0.03 % | 0.18 % | as of Mar 31, 2026 ↗ |
| ClearBridge Select Fund Legg Mason Partners Investment Trust | 477,363 | 9.1M $ | 0.28 % | 0.17 % | as of Apr 30, 2026 ↗ |
| JNL/T. Rowe Price Mid-Cap Growth Fund JNL Series Trust | 476,374 | 8.5M $ | 0.21 % | 0.17 % | as of Mar 31, 2026 ↗ |
| JNL/JPMorgan MidCap Growth Fund JNL Series Trust | 465,108 | 8.3M $ | 0.27 % | 0.16 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 426,121 | 7.6M $ | 0.09 % | 0.15 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Small Cap Opportunities Fund Fidelity Securities Fund | 404,000 | 7.7M $ | 0.15 % | 0.14 % | as of Apr 30, 2026 ↗ |
| Fidelity Advisor Stock Selector Mid Cap Fund Fidelity Advisor Series I | 390,000 | 7.9M $ | 0.34 % | 0.14 % | as of Feb 28, 2026 ↗ |
| LargeCap Growth Fund I Principal Funds, Inc | 383,792 | 7.3M $ | 0.12 % | 0.14 % | as of Apr 30, 2026 ↗ |
| JPMorgan Small Cap Growth Fund JPMorgan Trust II | 361,713 | 6.5M $ | 0.30 % | 0.13 % | as of Mar 31, 2026 ↗ |
| iShares Russell Mid-Cap ETF iShares Trust | 346,891 | 6.2M $ | 0.01 % | 0.12 % | as of Mar 31, 2026 ↗ |
| Multi-Manager Large Cap Growth Strategies Fund COLUMBIA FUNDS SERIES TRUST I | 343,823 | 6.1M $ | 0.13 % | 0.12 % | as of Mar 31, 2026 ↗ |
| Fidelity Mid Cap Index Fund Fidelity Salem Street Trust | 337,481 | 6.4M $ | 0.01 % | 0.12 % | as of Apr 30, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 336,115 | 6.8M $ | 0.03 % | 0.12 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Institutional Mid-Cap Equity Growth Fund T. Rowe Price Equity Funds, Inc. | 316,926 | 5.7M $ | 0.21 % | 0.11 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 308,141 | 6.2M $ | 0.03 % | 0.11 % | as of Feb 28, 2026 ↗ |
| iShares Russell Mid-Cap Growth ETF iShares Trust | 303,494 | 5.4M $ | 0.03 % | 0.11 % | as of Mar 31, 2026 ↗ |
| VIP Stock Selector Portfolio Variable Insurance Products Fund | 250,000 | 4.5M $ | 0.10 % | 0.09 % | as of Mar 31, 2026 ↗ |
| MassMutual Mid Cap Growth Fund MASSMUTUAL SELECT FUNDS | 249,038 | 4.5M $ | 0.16 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor Multi-Asset Income Fund Fidelity School Street Trust | 238,100 | 4.3M $ | 0.12 % | 0.08 % | as of Mar 31, 2026 ↗ |
| JPMorgan Mid Cap Equity Fund JPMorgan Trust I | 234,347 | 4.2M $ | 0.07 % | 0.08 % | as of Mar 31, 2026 ↗ |
| Fidelity Mid-Cap Stock K6 Fund Fidelity Concord Street Trust | 220,400 | 4.2M $ | 0.30 % | 0.08 % | as of Apr 30, 2026 ↗ |
| Empower T. Rowe Price Mid Cap Growth Fund EMPOWER FUNDS, INC. | 214,396 | 3.8M $ | 0.20 % | 0.08 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor Diversified Stock Fund Fidelity Destiny Portfolios | 213,500 | 3.8M $ | 0.10 % | 0.08 % | as of Mar 31, 2026 ↗ |
| iShares Genomics Immunology and Healthcare ETF iShares Trust | 205,671 | 3.9M $ | 2.44 % | 0.07 % | as of Apr 30, 2026 ↗ |
| Optimum Large Cap Growth Fund Optimum Fund Trust | 201,210 | 3.6M $ | 0.21 % | 0.07 % | as of Mar 31, 2026 ↗ |
| MidCap Value Fund I Principal Funds, Inc | 196,272 | 3.7M $ | 0.15 % | 0.07 % | as of Apr 30, 2026 ↗ |
| BlackRock Advantage Small Cap Core Fund BlackRock Funds | 193,829 | 3.9M $ | 0.09 % | 0.07 % | as of Feb 27, 2026 ↗ |
| Strategic Advisers U.S. Total Stock Fund Fidelity Rutland Square Trust II | 185,239 | 3.7M $ | 0.00 % | 0.07 % | as of Feb 28, 2026 ↗ |
| iShares Russell 1000 Growth ETF iShares Trust | 182,592 | 3.3M $ | 0.00 % | 0.06 % | as of Mar 31, 2026 ↗ |
| MFS New Discovery Fund MFS SERIES TRUST I | 177,080 | 3.6M $ | 0.17 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Nationwide Large Cap Equity Portfolio Nationwide Mutual Funds | 171,667 | 3.3M $ | 0.17 % | 0.06 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 170,866 | 3.4M $ | 0.02 % | 0.06 % | as of Feb 28, 2026 ↗ |
| SA JPMorgan Mid-Cap Growth Portfolio SUNAMERICA SERIES TRUST | 159,837 | 3M $ | 0.46 % | 0.06 % | as of Apr 30, 2026 ↗ |
| Mid Cap Growth Stock Portfolio NORTHWESTERN MUTUAL SERIES FUND INC | 142,881 | 2.6M $ | 0.27 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Federated Hermes Muni and Stock Advantage Fund Federated Hermes Income Securities Trust | 136,687 | 2.6M $ | 0.18 % | 0.05 % | as of Apr 30, 2026 ↗ |
| Eaton Vance Worldwide Health Sciences Fund Eaton Vance Growth Trust | 135,807 | 2.7M $ | 0.32 % | 0.05 % | as of Feb 28, 2026 ↗ |
| ClearBridge Variable Small Cap Growth Portfolio Legg Mason Partners Variable Equity Trust | 134,707 | 2.4M $ | 0.61 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor New Insights Fund Fidelity Contrafund | 132,267 | 2.4M $ | 0.01 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Virtus Zevenbergen Innovative Growth Stock Fund Virtus Asset Trust | 131,550 | 2.4M $ | 0.68 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Fidelity Blue Chip Growth Fund Fidelity Securities Fund | 131,226 | 2.5M $ | 0.00 % | 0.05 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Mid Cap Growth Portfolio Brighthouse Funds Trust I | 122,543 | 2.2M $ | 0.21 % | 0.04 % | as of Mar 31, 2026 ↗ |
| JPMorgan Small Cap Blend Fund JPMorgan Trust I | 116,774 | 2.1M $ | 0.15 % | 0.04 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 116,415 | 2.1M $ | 0.31 % | 0.04 % | as of Mar 31, 2026 ↗ |
| VIP Contrafund Portfolio Variable Insurance Products Fund II | 114,329 | 2M $ | 0.01 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Invesco Health Care Fund AIM Investment Funds (Invesco Investment Funds) | 110,484 | 2.1M $ | 0.19 % | 0.04 % | as of Apr 30, 2026 ↗ |
| iShares Russell 1000 Value ETF iShares Trust | 104,952 | 1.9M $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
| VIP Balanced Portfolio Variable Insurance Products Fund III | 98,900 | 1.8M $ | 0.02 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity Series All-Sector Equity Fund Fidelity Devonshire Trust | 96,600 | 1.8M $ | 0.03 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Fidelity Puritan K6 Fund Fidelity Puritan Trust | 92,972 | 1.9M $ | 0.08 % | 0.03 % | as of Feb 28, 2026 ↗ |
| Nuveen Equity Index Fund TIAA-CREF Funds | 77,115 | 1.5M $ | 0.00 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Fidelity Series Opportunistic Insights Fund Fidelity Contrafund | 76,716 | 1.4M $ | 0.01 % | 0.03 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 69,672 | 1.3M $ | 0.00 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 68,377 | 1.4M $ | 0.02 % | 0.02 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Integrated U.S. Small-Mid Cap Core Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 68,025 | 1.2M $ | 0.08 % | 0.02 % | as of Mar 31, 2026 ↗ |
| iShares Russell Mid-Cap Value ETF iShares Trust | 66,366 | 1.2M $ | 0.01 % | 0.02 % | as of Mar 31, 2026 ↗ |
| State Street Institutional Small-Cap Equity Fund STATE STREET INSTITUTIONAL FUNDS | 65,500 | 1.2M $ | 0.25 % | 0.02 % | as of Mar 31, 2026 ↗ |
| iShares Russell 1000 ETF iShares Trust | 64,968 | 1.2M $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Fidelity Large Cap Growth Index Fund Fidelity Salem Street Trust | 64,492 | 1.2M $ | 0.00 % | 0.02 % | as of Apr 30, 2026 ↗ |
| MFS New Discovery Series MFS VARIABLE INSURANCE TRUST | 63,553 | 1.1M $ | 0.16 % | 0.02 % | as of Mar 31, 2026 ↗ |
| VANGUARD TAX-MANAGED CAPITAL APPRECIATION FUND VANGUARD TAX-MANAGED FUNDS | 56,360 | 1M $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| T.Rowe Price Small Cap Growth Portfolio Brighthouse Funds Trust II | 55,875 | 999K $ | 0.09 % | 0.02 % | as of Mar 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 55,475 | 991.9K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Fidelity Mid Cap Growth Index Fund Fidelity Salem Street Trust | 55,353 | 989.7K $ | 0.03 % | 0.02 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Small-Mid Cap ETF T. Rowe Price Exchange-Traded Funds, Inc. | 54,433 | 973.3K $ | 0.06 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Multi-Manager Small Cap Equity Strategies Fund COLUMBIA FUNDS SERIES TRUST I | 53,716 | 1.1M $ | 0.09 % | 0.02 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Mid-Cap Growth Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 48,694 | 870.6K $ | 0.20 % | 0.02 % | as of Mar 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 46,903 | 838.6K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| iShares U.S. Healthcare ETF iShares Trust | 46,549 | 884.4K $ | 0.03 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Federated Hermes Capital Income Fund Federated Hermes Income Securities Trust | 45,962 | 925.7K $ | 0.14 % | 0.02 % | as of Feb 28, 2026 ↗ |
| Bridge Builder Tax Managed Small/Mid Cap Fund Bridge Builder Trust | 45,555 | 814.5K $ | 0.03 % | 0.02 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| iShares Genomics Immunology and Healthcare ETF iShares Trust | 2.44 % | as of Apr 30, 2026 ↗ |
| Select Medical Technology and Devices Portfolio Fidelity Select Portfolios | 1.49 % | as of Feb 28, 2026 ↗ |
| Nuveen Quant Mid Cap Growth Fund TIAA-CREF Funds | 1.47 % | as of Apr 30, 2026 ↗ |
| Fidelity Disruptive Medicine ETF Fidelity Covington Trust | 1.32 % | as of Feb 28, 2026 ↗ |
| First Trust Nasdaq Lux Digital Health Solutions ETF First Trust Exchange-Traded Fund II | 1.30 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor Health Care Fund Fidelity Advisor Series VII | 1.18 % | as of Apr 30, 2026 ↗ |
| VIP Health Care Portfolio Variable Insurance Products Fund IV | 1.05 % | as of Mar 31, 2026 ↗ |
| Select Health Care Portfolio Fidelity Select Portfolios | 0.99 % | as of Feb 28, 2026 ↗ |
| Global X Guru Index ETF GLOBAL X FUNDS | 0.99 % | as of Apr 30, 2026 ↗ |
| Champlain Small Company Fund ADVISORS' INNER CIRCLE FUND II | 0.97 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 237 | +33 | 57,120,292 | +96.3 % |
| 2026Q1 | 204 | +13 | 29,097,222 | +82.4 % |
| 2025Q4 | 191 | +73 | 15,951,263 | +76.3 % |
| 2025Q3 | 118 | 9,049,436 |
Institutional managers
195 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 30,785,585 | 550.4M $ | as of Mar 31, 2026 |
| J. H. Whitney Equity Partners VI, LLC | 18,256,615 | 326.4M $ | as of Mar 31, 2026 |
| Sixth Street Partners Management Company, L.P. | 14,385,399 | 257.2M $ | as of Mar 31, 2026 |
| COATUE MANAGEMENT LLC | 9,819,992 | 175.6M $ | as of Mar 31, 2026 |
| BRAIDWELL LP | 8,009,447 | 143.2M $ | as of Mar 31, 2026 |
| PointState Capital LP | 7,360,446 | 131.6M $ | as of Mar 31, 2026 |
| T. Rowe Price Investment Management, Inc. | 5,588,257 | 99.9K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 4,857,112 | 86.8M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 4,371,771 | 78.2K $ | as of Mar 31, 2026 |
| NEUBERGER BERMAN GROUP LLC | 3,590,586 | 64.2M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 3,460,215 | 58.3M $ | as of Mar 31, 2026 |
| ORBIMED ADVISORS LLC | 2,806,811 | 50.2M $ | as of Mar 31, 2026 |
| UBS Group AG | 2,745,811 | 49.1M $ | as of Mar 31, 2026 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 2,289,602 | 40.9M $ | as of Mar 31, 2026 |
| Duquesne Family Office LLC | 1,894,450 | 33.9K $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 1,614,286 | 28.9M $ | as of Mar 31, 2026 |
| Clearbridge Investments, LLC | 1,551,774 | 27.7M $ | as of Mar 31, 2026 |
| FIL Ltd | 1,546,091 | 27.6M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 1,527,756 | 27.3M $ | as of Mar 31, 2026 |
| CANADA PENSION PLAN INVESTMENT BOARD | 1,322,752 | 23.7M $ | as of Mar 31, 2026 |
| Invesco Ltd. | 1,222,278 | 21.9M $ | as of Mar 31, 2026 |
| Champlain Investment Partners, LLC | 1,207,963 | 21.6M $ | as of Mar 31, 2026 |
| Capital World Investors | 1,180,173 | 21.1M $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1,149,133 | 20.5M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,079,417 | 19.3M $ | as of Mar 31, 2026 |
Declared shareholders of Caris Life Sciences Inc
3 beneficial ownership filings. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| FMR LLC and 1 other | 10.80 % | 30,631,585 | as of Mar 31, 2026 · SCHEDULE 13G |
| J H Whitney VI L P and 3 others | 6.50 % | 18,256,615 | as of Mar 31, 2026 · SCHEDULE 13G |
| TSSP Sub-Fund HoldCo, LLC and 1 other | 5.10 % | 14,385,399 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Caris Life Sciences Inc". https://titelia.com/en/stocks/caris-life-sciences-inc-US1421521071